Penile Implants Market Trends

The growing prevalence of chronic diseases is a significant driver for penile implants industry. As the global population ages, there is a corresponding increase in the prevalence of chronic diseases and age-related sexual health issues, leading to a higher incidence of ED.

• Erectile dysfunction is strongly associated with various diseases and conditions including prediabetes, diabetes, hypertension, cardiovascular disease, obesity, and metabolic syndrome. These conditions can lead to damage to blood vessels, nerves, and tissues in the penis, impairing erectile function and increasing the likelihood of ED development or progression.
  
• According to the World Health Organization, in 2023, the prevalence of erectile dysfunction among obese men was 64.9% and among the morbidly obese was 72.4%. As per the same report, there were significant positive relationships between erectile dysfunction and having a chronic disease.
  
• Further, according to the National Institutes of Health, in 2023, in different regions of the world, the prevalence of diabetes mellitus-induced erectile dysfunction (DMED) ranges from 35.8% to 86.1%.
  
• Chronic diseases can directly affect erectile function by causing vascular insufficiency, neuropathy, hormonal imbalances, and endothelial dysfunction, which are common underlying mechanisms of ED. Thus, leading to the growth of the market.